Literature DB >> 26438181

Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.

Ali Pourjavadi1, Zahra Mazaheri Tehrani2, Azardokht Abedin Moghanaki2.   

Abstract

PURPOSE: The prime end of this study was to design a novel pH-sensitive as well as a PEGylated dendritic nanocarrier for both controllable and traceable gemcitabine delivery to cancerous cells. To accomplish this goal, we took advantage of a hybrid of nanoparticles including: mesoporous silica, graphene oxide and magnetite.
METHODS: The nanocarrier was prepared in a multi-step synthesis route. First, magnetite mesoporous silica was deposited on the graphene oxide matrix. Then, polyamidoamine dendrimers (up to generation 1.5) with pentaethylene hexamine end groups were grafted on the surface of the nanoparticles. In order to enhance the biostability, and as the next step, the nanocarrier was modified by polyethylene glycol. Finally, these particles were functionalized by folic acid as tumor targeting agents.
RESULTS: According to the dynamic light scattering results, the hydrodynamic diameter of magnetic mesoporous silica graphene oxide hybrid nanoparticle was 152 ± 3 nm, while for the supramolecular hybrid nanoparticles it was about 324 ± 12 nm. Attained through the adsorption branch, the average pore diameter of these nanoparticles was 7.6 nm. Zeta potential test indicated -27.1 mV value for hybrid nanoparticles and +7.35 mV for supramolecular hybrid nanoparticles. Besides, cytotoxicity assay showed enhanced cytotoxicity of epidermoid carcinoma cell line A431 in the presence of folate conjugated carriers. The maximum release occurred at the pH 5.5, because the dendritic structure was in the open state rather than compact state.
CONCLUSIONS: The enhanced cytotoxicity of the epidermoid carcinoma cell line A431 in the presence of folate conjugated carriers, confirmed the improved cancerous cells uptake. Also, the positive surface potential would be a good property for the biological applications because the inherent negative-charged surface of cell membranes facilitates the uptake of positive particles by electrostatic interactions.

Entities:  

Keywords:  folic acid; gemcitabine; graphene oxide; mesoporous silica; pH-responsive

Mesh:

Substances:

Year:  2015        PMID: 26438181     DOI: 10.1007/s11095-015-1799-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue.

Authors:  Fabian Fehlauer; Martina Muench; Ernst J Smid; Ben Slotman; Eckhard Richter; Paul Van der Valk; Peter Sminia
Journal:  Oncol Rep       Date:  2006-01       Impact factor: 3.906

2.  Graphene oxide-periodic mesoporous silica sandwich nanocomposites with vertically oriented channels.

Authors:  Zheng-Ming Wang; Wendong Wang; Neil Coombs; Navid Soheilnia; Geoffrey A Ozin
Journal:  ACS Nano       Date:  2010-11-23       Impact factor: 15.881

3.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Authors:  Ennio Tasciotti; Xuewu Liu; Rohan Bhavane; Kevin Plant; Ashley D Leonard; B Katherine Price; Mark Ming-Cheng Cheng; Paolo Decuzzi; James M Tour; Fredika Robertson; Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

Review 4.  Stimuli-responsive polymers and their applications in drug delivery.

Authors:  Priya Bawa; Viness Pillay; Yahya E Choonara; Lisa C du Toit
Journal:  Biomed Mater       Date:  2009-03-05       Impact factor: 3.715

5.  Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands.

Authors:  Jinlou Gu; Wei Fan; Atsushi Shimojima; Tatsuya Okubo
Journal:  Small       Date:  2007-10       Impact factor: 13.281

6.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Authors:  N Malik; R Wiwattanapatapee; R Klopsch; K Lorenz; H Frey; J W Weener; E W Meijer; W Paulus; R Duncan
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 7.  Targeted drug delivery via the folate receptor.

Authors:  J Sudimack; R J Lee
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

8.  Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma.

Authors:  Yi Wang; Kaiyuan Wang; Jianfeng Zhao; Xingang Liu; Juan Bu; Xueying Yan; Rongqin Huang
Journal:  J Am Chem Soc       Date:  2013-03-15       Impact factor: 15.419

Review 9.  Folate-mediated delivery of macromolecular anticancer therapeutic agents.

Authors:  Yingjuan Lu; Philip S Low
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

Review 10.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

Authors:  Philip S Low; Walter A Henne; Derek D Doorneweerd
Journal:  Acc Chem Res       Date:  2007-07-27       Impact factor: 22.384

View more
  8 in total

1.  A pH-Sensitive Nanocarrier for Tumor Targeting : Delivery of Ruthenium Complex for Tumor Theranostic by pH-Sensitive Nanocapsule.

Authors:  Ligang Chen; Chen Fu; Yajun Deng; Wei Wu; Ailing Fu
Journal:  Pharm Res       Date:  2016-09-02       Impact factor: 4.200

Review 2.  pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Bioengineering (Basel)       Date:  2017-01-18

3.  A Mixed Micelle Formulation for Oral Delivery of Vitamin K.

Authors:  Feilong Sun; Tessa C C Jaspers; Peter M van Hasselt; Wim E Hennink; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

4.  Release of Doxorubicin by a Folate-Grafted, Chitosan-Coated Magnetic Nanoparticle.

Authors:  Chung-Lin Yang; Jyh-Ping Chen; Kuo-Chen Wei; Ju-Yu Chen; Chia-Wen Huang; Zi-Xian Liao
Journal:  Nanomaterials (Basel)       Date:  2017-04-13       Impact factor: 5.076

5.  Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.

Authors:  Junjian Wang
Journal:  Drug Des Devel Ther       Date:  2020-02-26       Impact factor: 4.162

Review 6.  Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-05-09       Impact factor: 5.076

Review 7.  Superparamagnetic Iron Oxide Nanoparticles and Essential Oils: A New Tool for Biological Applications.

Authors:  Maria Graça Miguel; João Paulo Lourenço; Maria Leonor Faleiro
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

Review 8.  Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.

Authors:  Magdalena Jurczyk; Katarzyna Jelonek; Monika Musiał-Kulik; Artur Beberok; Dorota Wrześniok; Janusz Kasperczyk
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.